1 Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
2 Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.
Am J Respir Crit Care Med. 2016 Jun 1;193(11):1242-53. doi: 10.1164/rccm.201507-1311OC.
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation caused by a combination of airways disease (bronchiolitis) and parenchymal destruction (emphysema), whose relative proportion varies from patient to patient.
To explore and contrast the molecular pathogenesis of emphysema and bronchiolitis in COPD.
We used network analysis of lung transcriptomics (Affymetrix arrays) in 70 former smokers with COPD to compare differential expression and gene coexpression in bronchiolitis and emphysema.
We observed that in emphysema (but not in bronchiolitis) (1) up-regulated genes were enriched in ontologies related to B-cell homing and activation; (2) the immune coexpression network had a central core of B cell-related genes; (3) B-cell recruitment and immunoglobulin transcription genes (CXCL13, CCL19, and POU2AF1) correlated with emphysema severity; (4) there were lymphoid follicles (CD20(+)IgM(+)) with active B cells (phosphorylated nuclear factor-κB p65(+)), proliferation markers (Ki-67(+)), and class-switched B cells (IgG(+)); and (5) both TNFRSF17 mRNA and B cell-activating factor protein were up-regulated. These findings were by and large reproduced in a group of patients with incipient emphysema and when patients with emphysema were matched for the severity of airflow limitation of those with bronchiolitis.
Our study identifies enrichment in B cell-related genes in patients with COPD with emphysema that is absent in bronchiolitis. These observations contribute to a better understanding of COPD pathobiology and may open new therapeutic opportunities for patients with COPD.
慢性阻塞性肺疾病(COPD)的特征是慢性气流受限,由气道疾病(细支气管炎)和实质破坏(肺气肿)共同引起,其相对比例因患者而异。
探索并对比 COPD 中肺气肿和细支气管炎的分子发病机制。
我们使用 70 名曾吸烟的 COPD 患者的肺转录组学(Affymetrix 芯片)进行网络分析,比较细支气管炎和肺气肿中的差异表达和基因共表达。
我们观察到,在肺气肿(但不在细支气管炎)中:(1)上调的基因在与 B 细胞归巢和激活相关的本体论中富集;(2)免疫共表达网络具有以 B 细胞相关基因为核心的中心核心;(3)B 细胞募集和免疫球蛋白转录基因(CXCL13、CCL19 和 POU2AF1)与肺气肿严重程度相关;(4)存在带有活性 B 细胞(磷酸化核因子-κB p65(+))、增殖标志物(Ki-67(+))和类别转换 B 细胞(IgG(+))的淋巴滤泡(CD20(+)IgM(+));(5)TNFRSF17 mRNA 和 B 细胞激活因子蛋白均上调。这些发现基本上在一组早期肺气肿患者中得到了重现,并且当肺气肿患者与细支气管炎患者的气流受限严重程度相匹配时也是如此。
我们的研究在 COPD 伴肺气肿患者中发现了与 B 细胞相关基因的富集,而在细支气管炎患者中则没有。这些观察结果有助于更好地了解 COPD 的发病机制,并可能为 COPD 患者带来新的治疗机会。